HEOR Training

Course features

• Orientation to job related practical aspects for the HEOR professionals.
• Course provides simulation to real life working in HEOR department. Hence, it help to enhance the HEOR decision making process.
• Moreover course provides hands on training on pharmacoeconomic modeling. How the pharmacoeconomic calculations are carried out.
• Above all, the course provides access to Case Studies to learn about the HEOR.

Who should attend this course? 

• Those who are in working in drug discovery and development, and working on the commercialization of the pharmaceuticals.
• Professionals working in health care settings including payer organizations, health insurance industry, government, the life sciences, pharmaceutical and biomedical industries.
• Health care providers interested in health economics and outcomes research.
• Professionals working within Health Technology Assessment or reimbursement organizations and other areas where allocation of resources and decisions for coverage and access are relevant.
• Fresher or beginners, Those who want to make a career in pharmacoeconomic or in HEOR department.

Few of the similar courses

• Pharma Market Access
• Global Pharma Management
• International Drug Regulatory Affairs
• US Pharmaceutical and Biopharmaceutical Regulatory Affairs
• Drug Registration and Regulation in China
• Drug Discovery and Development to Commercialization
• European Drug Regulatory Affairs
• Drug Registration and Regulation in GCC countries
• UAE Drug Regulation and Registration

Key Topics covered in the HEOR training course 

The course is broken down into various lecture sessions:

• Introduction to Health Economics | Key terminologies related to health economics.
• HEOR Application in Pharmaceutical and Biopharmaceutical Industry.
• Introduction to Pharmacoeconomics | Different Types of Economic Evaluation | Cost-effectiveness plane | Economic modeling |Sensitivity Analysis | One way sensitivity analysis | Probabilistic sensitivity analysis.
• Economic Evaluation Methods | Various methods | Importance of perspective in health economics | Discounting | Uncertainty.
• Core fundamentals of Health Economics | Clinical and economic burden | Public Health Care Payer Vs. Patient and Societal | Positioning a new treatment with the current treatment | QALY | ICER | Threshold value | Clinical trials vs health economics assessment.
• Pharmacoeconomic Evaluation Checklist | Health Economics Map | Economic evaluation cycle | Checklist of economic evaluation | Costs and Outcome relevant to different groups | Comparators | Problem of choosing the comparators.
• Pharmacoeconomic Evaluation – Resource and Cost | Fixed, Variable and Total Cost | Calculation | Average vs. marginal cost | Importance of marginal cost | Discounting | Discounting calculation | Preferable discounting rate | Sources of unit cost data | Reference costs.
• Pharmacoeconomic Evaluation – Benefits and Outcome | C/E Ratio | Intermediate Vs. Final Outcome | Sources of Effectiveness Data | QALY | Utility Weight | WTP | VPF | ATP | Difference between WTP & ATP.
• CER and PCOR.
• Evidence Based Decision Making | Real World Evidence